63 related articles for article (PubMed ID: 37682614)
41. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
42. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
[TBL] [Abstract][Full Text] [Related]
43. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
[TBL] [Abstract][Full Text] [Related]
44. Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.
Luo Y; Pan Q; Zhang W; Li F
Clin Nucl Med; 2020 Apr; 45(4):310-311. PubMed ID: 31977474
[TBL] [Abstract][Full Text] [Related]
45. Increased FAPI Activity in Pulmonary Tuberculosis.
Liu W; Gong W; Yang X; Xu T; Chen Y
Clin Nucl Med; 2023 Feb; 48(2):188-189. PubMed ID: 36607369
[TBL] [Abstract][Full Text] [Related]
46. Hepatic radiation injury in distal esophageal carcinoma: a case report.
Wong JJ; Anthony MP; Lan Khong P
Clin Nucl Med; 2012 Jul; 37(7):709-11. PubMed ID: 22691523
[TBL] [Abstract][Full Text] [Related]
47. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
[TBL] [Abstract][Full Text] [Related]
48. Utility of [
Miao Y; Feng R; Guo R; Huang X; Hai W; Li J; Yu T; Qu Q; Zhang M; Shangguan C; Mi J; Zhu Z; Li B
Eur Radiol; 2023 Jun; 33(6):4355-4366. PubMed ID: 36522509
[TBL] [Abstract][Full Text] [Related]
49. [
Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
[TBL] [Abstract][Full Text] [Related]
50. Increased 18F-FAPI PET/CT Uptake in a Case of Brucellosis of Lumbar Vertebral Body.
Mu X; Zhu Z; Fu W
Clin Nucl Med; 2023 Jan; 48(1):75-76. PubMed ID: 36469064
[TBL] [Abstract][Full Text] [Related]
51. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
Xie F; Fu L; Zhou W
Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
[TBL] [Abstract][Full Text] [Related]
52. Phantom simulation of liver metastasis on a positron emission tomography with computed tomography scan after neoadjuvant chemoradiotherapy for distal esophageal cancer: a case report.
Shai SE; Lin YH; Lai YL; Tang HW; Hsieh YW; Hung SC
J Med Case Rep; 2020 Jul; 14(1):106. PubMed ID: 32631396
[TBL] [Abstract][Full Text] [Related]
53. Increased 18F-FAPI Uptake in Radiation-Induced Liver Injury.
Zhang J; Jiang S; Zhang R; Zhang L
Clin Nucl Med; 2023 Oct; 48(10):e474-e476. PubMed ID: 37682614
[TBL] [Abstract][Full Text] [Related]
54. Intense 18 F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18 F-FDG PET/CT.
Liang J; Zhang J; Song J; Zhang R; Zhang L
Clin Nucl Med; 2024 Jul; 49(7):e351-e353. PubMed ID: 38569540
[TBL] [Abstract][Full Text] [Related]
55. A Case of Liver Injury Mimicking Metastasis After Gamma Knife Therapy for Lung Cancer: Evaluating by 18F-FDG PET/CT.
Tang K; Zheng X; Lin J; Yin W
Clin Nucl Med; 2018 Nov; 43(11):860-863. PubMed ID: 30222682
[TBL] [Abstract][Full Text] [Related]
56. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
